Coastal customers bank stem cells for longevity, Midwest customers for disease treatment
Steven Klausnitzer · 983 200 People Have Paid Him $2k To Live Forever · Apr 3, 2018 · at 14:23
Steven Klausnitzer, CEO of stem cell banking startup Forever Labs, contrasts customer motivations across the startup's regional US markets.
0:00 / 0:16exact quote · 16.3s
720p mp4 · rendered on demand · StarZero watermark
“If we're in Michigan or North Carolina it's a much more pragmatic market. People signing up there are signing up in order to treat perhaps a family disease. They may have a family history of cardiovascular disease. Or osteoarthritis or rheumatoid arthritis, what have you. People in San Francisco and LA though, they're looking at longevity, right?”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Steven Klausnitzer
Johns Hopkins researchers replaced heart attack scar tissue using banked stem cells
“At Johns Hopkins, they took these bone marrow derived mesenchymal stem cells, that same ones we store for you. And they grew them and introduced them into the damaged area of a person's heart after they had a heart attack. And they were able to grow healthy ti…”
Steven Klausnitzer plans to intravenously reintroduce his banked 38-year-old stem cells
“So I want, I'm going to take my thirty-eight-year-old cells when I'm, I think, about 45 years old. I'm going to grow them, and I'm going to start reintroducing them intravenously. And not to treat any specific disease or just to reconstitute my stem cell.”
Klausnitzer argues reactive disease treatment is inferior to proactive cellular maintenance
“We can do that now at the cellular level. So that's what I'm talking about as far as health maintenance. So we're a disease treatment society. It's ridiculous. We wait till our body breaks down and then we try to get it back to homeostasis. It's silly, really,…”
Klausnitzer: Over 500 clinical trials use banked stem cells for aging diseases
“And there are over 500 clinical trials that are using the cells we store to treat age related diseases.”